Middle-stage Alzheimer's disease is marked by noticeable cognitive decline that affects daily functioning. Individuals may struggle with memory loss, forgetfulness of recent events or people's names, and difficulty with problem-solving tasks. Behavioral changes such as increased anxiety, confusion, and agitation may also occur. Communication becomes challenging as language skills decline, and individuals may repeat themselves or struggle to find the right words. Personal care and managing daily activities independently become increasingly difficult. Caregivers play a crucial role in providing support during this stage, assisting with daily tasks, ensuring safety, and maintaining a comforting environment. Medical management focuses on symptom relief and support to enhance quality of life for both patients and caregivers navigating this progressive neurological condition.
Jacqueline Tuppen
Cogs Club, United Kingdom
Yong Xiao Wang
Albany Medical College, United States
Kaoru Sakatani
The University of Tokyo, Japan
Suren A Tatulian
University of Central Florida, United States
Constantina Mizis
The Latino Alzheimer’s and Memory Disorders Alliance, United States
Paul Y Song
NKGen Biotech, United States
Marco Ruggiero
Silver Spring Sagl, Switzerland
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States